Breaking News Instant updates and real-time market news.

FLXN

Flexion

$12.39

-0.02 (-0.16%)

16:07
01/03/19
01/03
16:07
01/03/19
16:07

Flexion sees FY19 Zilretta product revenue $ $65M-$80M

  • 04

    Jan

FLXN Flexion
$12.39

-0.02 (-0.16%)

12/31/18
WELS
12/31/18
NO CHANGE
Target $26
WELS
Outperform
Flexion price target lowered to $26 from $39 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Flexion to $26 from ahead of updated 2019 guidance and given the stock's underperformance in 2019. Maris believes 2019 is a critical year for Flexion to execute on the Zilretta opportunity. The analyst reiterates an Outperform rating on the shares.
11/30/18
WELS
11/30/18
NO CHANGE
Target $39
WELS
Outperform
Wells 'very excited' about Flexion prospects after management meeting
After attending investor meetings with management, Wells Fargo analyst David Maris says he remains "very excited" about the company's prospects and that he believes 2019 will be a "transformational" year. Flexion continues to feel upbeat about the Zilretta launch and is very pleased with how it is progressing at this stage as momentum continues to build, Maris tells investors in a research note. He maintains an Outperform rating on the shares with a $39 price target.
11/27/18
RBCM
11/27/18
NO CHANGE
RBCM
RBC Capital likes select Specialty Pharma names on recent sector selling
RBC Capital analyst Randall Stanicky is positive on Amneal Pharmaceuticals (AMRX), Endo International (ENDP), Flexion Therapeutics (FLXN), Jazz Pharmaceuticals (JAZZ) as his top selections in Specialty Pharma, saying the sector has come under particular pressure in the most recent market sell-off. The analyst anticipates Amneal Pharmaceuticals to benefit from a cyclical generics recovery in the 2nd half of 2019, saying its "valuation is compelling against growth outlook". For Endo International, Stanicky sees the cellulite data driven selloff as overdone and believes that its low valuation helps to set a floor for the stock. For Flexion, the analyst anticipates a 2019 inflection on ramping Zilretta launch, adding that its 32% short interest is "hard to ignore". For Jazz Pharma, Stanicky points to a re-set of expectations around Vyxeos in Q3 as the company enters a "catalyst-heavy path led by December 20th solriamfetol PDUFA" and a material discount in valuation. The analyst maintain his Outperform rating on these four stocks.
11/05/18
WELS
11/05/18
NO CHANGE
WELS
Outperform
Wells says Flexion assignment of J-code for Zilretta lifts 'major' overhang
Wells Fargo analyst David Maris sees Flexion shares to be up following the announcement that CMS has issued a product specific J-code for Zilretta, as he believes the news lifts a "major overhang" on the stock. While he saw little risk that Flexion would not get a J-code to facilitate ease of reimbursement and access for patients, some investors had been worried about this issue, Maris noted. He also thinks the J-code should help drive an inflection in Zilretta sales in 2019. Maris keeps an Outperform rating on Flexion shares.

TODAY'S FREE FLY STORIES

ALB

Albemarle

$67.72

-0.29 (-0.43%)

06:27
11/12/19
11/12
06:27
11/12/19
06:27
Downgrade
Albemarle rating change  »

Albemarle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 12

    Dec

EPAY

Bottomline Technologies

$46.65

1.33 (2.93%)

06:24
11/12/19
11/12
06:24
11/12/19
06:24
Recommendations
Bottomline Technologies analyst commentary  »

Citi added Bottomline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 21

    Nov

  • 09

    Dec

  • 11

    Dec

PRCP

Perceptron

$4.56

(0.00%)

06:21
11/12/19
11/12
06:21
11/12/19
06:21
Hot Stocks
Perceptron announces Chairman Jay Freeland named Interim CEO »

Perceptron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 18

    Nov

STOK

Stoke Therapeutics

$29.83

-0.17 (-0.57%)

06:20
11/12/19
11/12
06:20
11/12/19
06:20
Initiation
Stoke Therapeutics initiated  »

Stoke Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,298.76

-10.6 (-0.81%)

, GOOGL

Alphabet Class A

$1,297.98

-10 (-0.76%)

06:20
11/12/19
11/12
06:20
11/12/19
06:20
Periodicals
Google quietly working with health system on healthcare data project, BI reports »

Google has been quietly…

GOOG

Alphabet

$1,298.76

-10.6 (-0.81%)

GOOGL

Alphabet Class A

$1,297.98

-10 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPC

Edgewell Personal Care

$36.46

-0.81 (-2.17%)

06:19
11/12/19
11/12
06:19
11/12/19
06:19
Earnings
Edgewell Personal Care sees FY20 adj. EPS $3.10-$3.30. consensus $3.32 »

Sees FY20 revenue down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

XPO

XPO Logistics

$84.16

-0.45 (-0.53%)

06:19
11/12/19
11/12
06:19
11/12/19
06:19
Recommendations
XPO Logistics analyst commentary  »

Citi sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$218.99

-3.93 (-1.76%)

, AAPL

Apple

$262.16

1.96 (0.75%)

06:18
11/12/19
11/12
06:18
11/12/19
06:18
Periodicals
Goldman to let Apple Card customers appearl credit limit, BI reports »

Goldman Sachs (GS) will…

GS

Goldman Sachs

$218.99

-3.93 (-1.76%)

AAPL

Apple

$262.16

1.96 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CWK

Cushman & Wakefield

$18.92

0.24 (1.28%)

06:16
11/12/19
11/12
06:16
11/12/19
06:16
Syndicate
Cushman & Wakefield files to sell 10M ordinary shares for holders »

Morgan Stanley is serving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$3.66

-0.09 (-2.40%)

06:16
11/12/19
11/12
06:16
11/12/19
06:16
Downgrade
Hudbay Minerals rating change  »

Hudbay Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RETA

Reata Pharmaceuticals

$213.52

1.48 (0.70%)

06:15
11/12/19
11/12
06:15
11/12/19
06:15
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

OII

Oceaneering

$13.99

-0.29 (-2.03%)

06:13
11/12/19
11/12
06:13
11/12/19
06:13
Initiation
Oceaneering initiated  »

Oceaneering resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$169.97

1.81 (1.08%)

06:12
11/12/19
11/12
06:12
11/12/19
06:12
Recommendations
Allegiant Travel analyst commentary  »

Allegiant Travel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$60.29

-0.31 (-0.51%)

06:09
11/12/19
11/12
06:09
11/12/19
06:09
Recommendations
AerCap analyst commentary  »

AerCap price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WU

Western Union

$27.35

-0.52 (-1.87%)

06:09
11/12/19
11/12
06:09
11/12/19
06:09
Downgrade
Western Union rating change  »

Western Union downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBS

UBS

$12.41

-0.01 (-0.08%)

06:07
11/12/19
11/12
06:07
11/12/19
06:07
Hot Stocks
UBS fined by Hong Kong regulator for overcharging clients »

Hong Kong's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

HLX

Helix Energy

$8.56

0.03 (0.35%)

06:07
11/12/19
11/12
06:07
11/12/19
06:07
Initiation
Helix Energy initiated  »

Helix Energy reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

FENC

Fennec

$5.24

0.13 (2.54%)

06:06
11/12/19
11/12
06:06
11/12/19
06:06
Earnings
Fennec reports Q3 EPS (9c), consensus (20c) »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDNT

RadNet

$16.14

0.09 (0.56%)

06:06
11/12/19
11/12
06:06
11/12/19
06:06
Hot Stocks
Breaking Hot Stocks news story on RadNet »

RadNet raises FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

KBR

KBR

$29.63

0.44 (1.51%)

06:05
11/12/19
11/12
06:05
11/12/19
06:05
Hot Stocks
KBR ROSE technology selected for modernization project at India refinery »

KBR announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

RDNT

RadNet

$16.14

0.09 (0.56%)

06:05
11/12/19
11/12
06:05
11/12/19
06:05
Earnings
RadNet backs FY19 revenue view $1.1B-$1.15B, consensus $1.13B »

Backs FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

OII

Oceaneering

$13.99

-0.29 (-2.03%)

06:05
11/12/19
11/12
06:05
11/12/19
06:05
Initiation
Oceaneering initiated  »

Oceaneering initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DYNT

Dynatronics

$0.84

0.0296 (3.65%)

06:04
11/12/19
11/12
06:04
11/12/19
06:04
Earnings
Breaking Earnings news story on Dynatronics »

Dynatronics backs FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 04

    Dec

NOG

Northern Oil and Gas

$2.06

-0.07 (-3.29%)

06:04
11/12/19
11/12
06:04
11/12/19
06:04
Hot Stocks
Northern Oil and Gas sees FY19 production 38,750BOE-39,150BOE per day »

Sees FY19 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 20

    Nov

RDNT

RadNet

$16.14

0.09 (0.56%)

06:04
11/12/19
11/12
06:04
11/12/19
06:04
Earnings
RadNet reports Q3 adjusted EPS 8c, consensus 10c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.